Please login to the form below

Not currently logged in
Email:
Password:

Glyconics appoints CEO

Dr Kam Pooni joins the UK diagnostics firm

UK disease management diagnostics firm Glyconics has appointed Dr Kam Pooni as chief executive officer with immediate effect.

Dr Pooni succeeds current chief executive Dr Berwyn Clarke who becomes chairman, while Dr Mike Lewis moves from chairman to non-executive director.

With over 19 years experience in leading life science businesses, Dr Pooni joins Glyconics from Astellas Pharmaceutical Europe where he served as senior director of European commercial operations and effectiveness among other roles.

Dr Clarke said: “Kam is a proven leader, with an impressive combination of vision, passion and experience building and managing pharmaceutical businesses and will play a major role in the development of the business as well as bringing additional experience to the board.

“I look forward to working closely with him at this exciting stage of the company's development.”

11th November 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics